NLS Pharmaceutics Changes EGM Record Date
Ticker: NCEL · Form: 6-K · Filed: Oct 1, 2024 · CIK: 1783036
| Field | Detail |
|---|---|
| Company | Nls Pharmaceutics LTD. (NCEL) |
| Form Type | 6-K |
| Filed Date | Oct 1, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $1 b, $2,500,000, $1.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: meeting-update, corporate-governance
Related Tickers: NLS
TL;DR
NLS Pharma pushed back EGM record date to Sept 9 due to invite delays.
AI Summary
NLS Pharmaceutics Ltd. announced on September 27, 2024, that it has changed the record date for its extraordinary general meeting. The meeting, originally scheduled for October 3, 2024, now has a new record date of September 9, 2024, 11:59 p.m. CET, moved from the previous September 10, 2024, record date. This adjustment was necessitated by a delay in the distribution and publication of the meeting's invitation.
Why It Matters
This change in record date could affect which shareholders are eligible to vote at the upcoming extraordinary general meeting, potentially influencing the outcome of any decisions made.
Risk Assessment
Risk Level: low — The filing is a procedural update regarding a meeting date, with no immediate financial or operational impact disclosed.
Key Players & Entities
- NLS Pharmaceutics Ltd. (company) — Registrant
- September 27, 2024 (date) — Date of Board of Directors' amendment
- October 3, 2024 (date) — Original date of Extraordinary General Meeting
- September 9, 2024, 11:59 p.m. CET (date) — New record date for Extraordinary General Meeting
- September 10, 2024 (date) — Previous record date for Extraordinary General Meeting
FAQ
What is the new record date for NLS Pharmaceutics' extraordinary general meeting?
The new record date is September 9, 2024, 11:59 p.m. CET.
Why was the record date changed?
The record date was changed due to a delay in the dispatch and publication of the invitation for the Meeting.
What was the original record date?
The original record date was September 10, 2024, 11:59 p.m. CET.
When is the extraordinary general meeting now scheduled to take place?
The extraordinary general meeting is scheduled to take place on October 3, 2024.
Who made the decision to change the record date?
The Board of Directors of NLS Pharmaceutics Ltd. amended the record date.
Filing Stats: 565 words · 2 min read · ~2 pages · Grade level 13.4 · Accepted 2024-10-01 16:01:13
Key Financial Figures
- $1 b — ’s failure to maintain at least a $1 bid price per share over the course of 30
- $2,500,000 — that it did not comply with the minimum $2,500,000 stockholders’ equity requirement
- $1.00 — , which requires a minimum bid price of $1.00 of the Registrant ’s common share
Filing Documents
- ea0216382-6k_nlspharma.htm (6-K) — 13KB
- 0001213900-24-084023.txt ( ) — 14KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. NLS Pharmaceutics Ltd. Date: October 1, 2024 By: /s/ Alexander C. Zwyer Name: Alexander C. Zwyer Title: Chief Executive Officer 2